Flag-neo-PP1-Alpha-H248K
(Plasmid
#171268)
-
PurposeMammalian expression of 3x-Flag-tagged human PP1 alpha catalytic subunit H248K mutant that loses enzymatic activity
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 171268 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonep3XFLAG-CMV-10
-
Backbone manufacturerSigma-Aldrich
- Backbone size w/o insert (bp) 6400
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name3x-Flag-tagged human PP1 alpha catalytic subunit H248K mutant
-
Alt namePP1-Alpha-H248K
-
Alt namePPP1CA-H248K
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1000
-
MutationPPP1CA-His248Lys (H248K)
-
Entrez GenePPP1CA (a.k.a. PP-1A, PP1A, PP1alpha, PPP1A)
- Promoter CMV
-
Tag
/ Fusion Protein
- Flag (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site HindIII (unknown if destroyed)
- 3′ cloning site BamHI (unknown if destroyed)
- 5′ sequencing primer CMV_fwd_primer (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The construction is based on PCR amplification using Pfu DNA polymerase and DNA mutagenesis.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Flag-neo-PP1-Alpha-H248K was a gift from Steven Balk (Addgene plasmid # 171268 ; http://n2t.net/addgene:171268 ; RRID:Addgene_171268) -
For your References section:
Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation. Liu X, Han W, Gulla S, Simon NI, Gao Y, Cai C, Yang H, Zhang X, Liu J, Balk SP, Chen S. Oncotarget. 2016 Jan 12;7(2):1754-64. doi: 10.18632/oncotarget.6434. 10.18632/oncotarget.6434 PubMed 26636645